| Human Wharton's jelly-derived stem cells display a distinct immunomodulatory and proregenerative transcriptional signature compared to bone marrow-derived stem cells R Donders, JFJ Bogie, S Ravanidis, P Gervois, M Vanheusden, R Maree, ... Stem cells and development 27 (2), 65-84, 2018 | 112 | 2018 |
| Human Wharton's jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis R Donders, M Vanheusden, JFJ Bogie, S Ravanidis, K Thewissen, ... Cell transplantation 24 (10), 2077-2098, 2015 | 100 | 2015 |
| Unraveling the pathways to neuronal homeostasis and disease: mechanistic insights into the role of RNA-binding proteins and associated factors S Ravanidis, FG Kattan, E Doxakis International journal of molecular sciences 19 (8), 2280, 2018 | 75 | 2018 |
| Circulating brain‐enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease S Ravanidis, A Bougea, N Papagiannakis, M Maniati, C Koros, AM Simitsi, ... Movement disorders 35 (3), 457-467, 2020 | 61 | 2020 |
| Differentially expressed circular RNAs in peripheral blood mononuclear cells of patients with Parkinson's disease S Ravanidis, A Bougea, D Karampatsi, N Papagiannakis, M Maniati, ... Movement Disorders 36 (5), 1170-1179, 2021 | 56 | 2021 |
| Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients S Ravanidis, A Bougea, N Papagiannakis, C Koros, AM Simitsi, I Pachi, ... Annals of clinical and translational neurology 7 (9), 1594-1607, 2020 | 53 | 2020 |
| Cerebral cortical circuitry formation requires functional glycine receptors G Morelli, A Avila, S Ravanidis, N Aourz, RL Neve, I Smolders, RJ Harvey, ... Cerebral Cortex 27 (3), 1863-1877, 2017 | 39 | 2017 |
| RNA-binding proteins implicated in mitochondrial damage and mitophagy S Ravanidis, E Doxakis Frontiers in cell and developmental biology 8, 372, 2020 | 29 | 2020 |
| Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells S Ravanidis, JFJ Bogie, R Donders, D Craeye, RW Mays, R Deans, ... Stem Cell Research & Therapy 6, 1-17, 2015 | 18 | 2015 |
| Fasting-mediated metabolic and toxicity reprogramming impacts circulating microRNA levels in humans S Ravanidis, F Grundler, FW de Toledo, E Dimitriou, F Tekos, Z Skaperda, ... Food and Chemical Toxicology 152, 112187, 2021 | 14 | 2021 |
| Subcutaneous transplantation of neural precursor cells in experimental autoimmune encephalomyelitis reduces chemotactic signals in the central nervous system S Ravanidis, KN Poulatsidou, R Lagoudaki, O Touloumi, E Polyzoidou, ... Stem cells translational medicine 4 (12), 1450-1462, 2015 | 12 | 2015 |
| Neuroprotective and anti‐inflammatory mechanisms are activated early in O ptic N euritis A Tsakiri, S Ravanidis, R Lagoudaki, KN Poulatsidou, IM Svane, ... Acta Neurologica Scandinavica 131 (5), 305-312, 2015 | 12 | 2015 |
| Crosstalk with inflammatory macrophages shapes the regulatory properties of multipotent adult progenitor cells S Ravanidis, JFJ Bogie, R Donders, R Deans, JJA Hendriks, P Stinissen, ... Stem Cells International 2017 (1), 2353240, 2017 | 7 | 2017 |
| Immunophenotype of mouse cerebral hemispheres-derived neural precursor cells KN Poulatsidou, R Lagoudaki, O Touloumi, E Kesidou, M Boziki, ... Neuroscience Letters 611, 33-39, 2016 | 3 | 2016 |
| Neural precursor cells improve clinical outcome of experimental autoimmune encephalomyelitis via reduced chemotaxis of peripheral lymphocytes S Ravanidis, KN Poulatsidou, M Arsenakis, N Grigoriadis, E Polyzoidou, ... 20th Meeting of the European-Neurological-Society, 2010 | 2 | 2010 |
| EE454 Budget Impact Analysis of Bimekizumab for the Treatment of Axial Spondyloarthritis (axSpA) in Greece M Koulentaki, S Ravanidis, D Daoussis, T Dimitroulas, C Papagoras, ... Value in Health 27 (12), S145, 2024 | | 2024 |
| EE784 Cost-Effectiveness Analysis of Bimekizumab in Patients With Active Psoriatic Arthritis (PSA) in Greece M Koulentaki, S Ravanidis, D Daoussis, T Dimitroulas, C Papagoras, ... Value in Health 27 (12), S209, 2024 | | 2024 |
| EE281 Cost-Effectiveness Analysis of Bimekizumab in Patients With Axial Spondyloarthritis (AXSPA) in Greece M Koulentaki, S Ravanidis, D Daoussis, T Dimitroulas, C Papagoras, ... Value in Health 27 (12), S109, 2024 | | 2024 |
| EE282 Budget Impact Analysis of Ivosidenib in Combination With Azacitidine for the Treatment of Previously Untreated mIDH1 Positive Acute Myeloid Leukaemia (AML) Patients … M Koulentaki, S Ravanidis, K Vellopoulou, F Karathanou, ... Value in Health 27 (12), S109, 2024 | | 2024 |
| RWD195 Persistence Rates of Second-Line Biologics in Psoriasis Following First-Line Biologic Treatment Based on Nationwide Data From Greece S Ravanidis, G Stefanou, A Tsolakidis, K Mathioudakis, E Lazaridou, ... Value in Health 27 (12), S612, 2024 | | 2024 |
Epaminondas DoxakisBiomedical Research Foundation, Academy of Athens在 bioacademy.gr 的电子邮件经过验证
